GlassScriptPhysician profile
Ignacio Jose Ranero
NPI 1093187064
$582.51
in general payments reported to CMS, 2019-2025
13 companies · $128 in 2025
The $128 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.87 · 2021: $79.78 · 2022: $56.56 · 2023: $76.70 · 2024: $209 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $145.91 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $97.62 | 2023-2025 | |
| Amgen INC. | $88.07 | 2020-2025 | Repatha, Otezla, Repatha |
| Esperion Therapeutics, INC. | $50.79 | 2021 | |
| Lilly USA, LLC | $49.40 | 2021-2024 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $27.78 | 2022 | |
| Abbvie INC. | $27.38 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $24.38 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.11 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.34 | 2024 | Tradjenta, Jardiance |
| Philips North America LLC | $13.81 | 2024 | (Ck7) Extended Holter |
| Shield Therapeutics INC | $13.39 | 2024 | |
| Intuity Medical INC | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignacio Ranero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.